Cibus CBUS
NASDAQ CBUS
$1.70 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cibus (CBUS) Change in Accured Expenses (2016 - 2025)

Cibus (CBUS) posted Change in Accured Expenses of $307000.0 for Q4 2025, up 106.57% sequentially from -$4.7 million in Q3 2025, and up 230.11% YoY from $93000.0 in Q4 2024.

Cibus (CBUS) Change in Accured Expenses (2016 - 2025) Analysis & Trends

Cibus has reported Change in Accured Expenses for 10 years, with the latest figure at $307000.0 in Q4 2025.

  • Quarterly Change in Accured Expenses rose 230.11% year-over-year to $307000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$367000.0 (up 31.4% YoY) and the FY2025 annual result came in at -$367000.0, up 31.4% from the prior year.
  • Change in Accured Expenses advanced to $307000.0 in Q4 2025 per CBUS's latest filing, from -$4.7 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $4.7 million in Q2 2025 and troughed at -$4.7 million in Q3 2025.
  • A 5-year average of $28200.0 and a median of $65000.0 in 2022 frame the typical range for Change in Accured Expenses.
  • The widest YoY moves for Change in Accured Expenses: up 2694.74% in 2023, down 578.01% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $238000.0 in 2021, then plunged by 115.97% to -$38000.0 in 2022, then jumped by 2694.74% to $986000.0 in 2023, then tumbled by 90.57% to $93000.0 in 2024, then surged by 230.11% to $307000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $307000.0, -$4.7 million, and $4.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cibus 129.72 Mn 109.29 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 307,000.00
Dec 31, 2025 307,000.00
Sep 30, 2025 -4.67 Mn
Sep 30, 2025 -4.67 Mn
Jun 30, 2025 4.74 Mn
Jun 30, 2025 4.74 Mn
Mar 31, 2025 -745,000.00
Mar 31, 2025 -745,000.00
Dec 31, 2024 93,000.00
Dec 31, 2024 93,000.00
Sep 30, 2024 -1.65 Mn
Sep 30, 2024 -1.65 Mn
Jun 30, 2024 1.58 Mn
Jun 30, 2024 1.58 Mn
Mar 31, 2024 -554,000.00
Mar 31, 2024 -554,000.00
Dec 31, 2023 986,000.00
Dec 31, 2023 986,000.00
Sep 30, 2023 -1.39 Mn
Sep 30, 2023 -1.39 Mn